Last reviewed · How we verify
Ad26.ZIKV.001 5*10^10 vp
Ad26.ZIKV.001 5*10^10 vp is a Biologic drug developed by Janssen Vaccines & Prevention B.V.. It is currently in Phase 1 development. Also known as: JNJ-66684657.
At a glance
| Generic name | Ad26.ZIKV.001 5*10^10 vp |
|---|---|
| Also known as | JNJ-66684657 |
| Sponsor | Janssen Vaccines & Prevention B.V. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ad26.ZIKV.001 5*10^10 vp CI brief — competitive landscape report
- Ad26.ZIKV.001 5*10^10 vp updates RSS · CI watch RSS
- Janssen Vaccines & Prevention B.V. portfolio CI
Frequently asked questions about Ad26.ZIKV.001 5*10^10 vp
What is Ad26.ZIKV.001 5*10^10 vp?
Ad26.ZIKV.001 5*10^10 vp is a Biologic drug developed by Janssen Vaccines & Prevention B.V..
Who makes Ad26.ZIKV.001 5*10^10 vp?
Ad26.ZIKV.001 5*10^10 vp is developed by Janssen Vaccines & Prevention B.V. (see full Janssen Vaccines & Prevention B.V. pipeline at /company/janssen-vaccines-prevention-b-v).
Is Ad26.ZIKV.001 5*10^10 vp also known as anything else?
Ad26.ZIKV.001 5*10^10 vp is also known as JNJ-66684657.
What development phase is Ad26.ZIKV.001 5*10^10 vp in?
Ad26.ZIKV.001 5*10^10 vp is in Phase 1.
Related
- Manufacturer: Janssen Vaccines & Prevention B.V. — full pipeline
- Also known as: JNJ-66684657
- Compare: Ad26.ZIKV.001 5*10^10 vp vs similar drugs
- Pricing: Ad26.ZIKV.001 5*10^10 vp cost, discount & access